In this episode of Branching Out, Elizabeth Shea sits down with Jim Datovech, former CEO of LKC Technologies, to explore the long road from acquiring a medical device company to refining the product and orchestrating a successful exit. Jim shares how a deal that died at the last minute unexpectedly validated the company’s scalability and paved the way for a stronger deal months later. He offers candid insights on disciplined spending, legal preparedness, the importance of marketing to suitors...
All content for Branching Out: TreeFork Strategies is the property of Elizabeth Shea and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Branching Out, Elizabeth Shea sits down with Jim Datovech, former CEO of LKC Technologies, to explore the long road from acquiring a medical device company to refining the product and orchestrating a successful exit. Jim shares how a deal that died at the last minute unexpectedly validated the company’s scalability and paved the way for a stronger deal months later. He offers candid insights on disciplined spending, legal preparedness, the importance of marketing to suitors...
When Cultures Collide - Interview with Susan Apgood
Branching Out: TreeFork Strategies
30 minutes
1 month ago
When Cultures Collide - Interview with Susan Apgood
In this episode of Branching Out, Susan Apgood, the former CEO of News Generation, shares candid insights about her journey selling her company in April 2020 in the midst of the COVID lockdown. She opens up about navigating a challenging broker relationship, unexpected cultural clashes between merging teams after the acquisition, and the emotional reality of watching a company you built change in ways you didn’t foresee. Susan also reflects on why due diligence, communication, and support net...
Branching Out: TreeFork Strategies
In this episode of Branching Out, Elizabeth Shea sits down with Jim Datovech, former CEO of LKC Technologies, to explore the long road from acquiring a medical device company to refining the product and orchestrating a successful exit. Jim shares how a deal that died at the last minute unexpectedly validated the company’s scalability and paved the way for a stronger deal months later. He offers candid insights on disciplined spending, legal preparedness, the importance of marketing to suitors...
